Programmed cell death mechanisms in neurological disease

Area of Science:

• Cell Biology
• Molecular Biology
• Pathology

Background:

• Programmed cell death (PCD) is an active cellular self-destruction process vital for nervous system development and response to injury.
• Modulators of PCD are implicated in neurodegeneration, cancer, and ischemic vascular disease.
• While apoptosis is extensively studied, emerging evidence points to non-apoptotic PCD forms, like autophagic cell death.

Purpose of the Study:

• To explore the existence and characteristics of non-apoptotic programmed cell death pathways.
• To propose a mechanistic taxonomy of PCD based on inhibitors, activators, and biochemical pathways.
• To enhance understanding of cell death in disease and identify novel therapeutic strategies.

Main Methods:

• Review of existing literature on programmed cell death, focusing on apoptosis and emerging non-apoptotic forms.
• Analysis of biochemical pathways, inhibitors, and activators associated with different PCD modalities.
• Comparative analysis to identify distinct features of various programmed cell death mechanisms.

Main Results:

• Evidence suggests the existence of programmed cell death forms beyond apoptosis and autophagic cell death.
• These additional PCD pathways may not fit established apoptotic or autophagic criteria.
• Understanding these diverse PCD mechanisms is crucial for disease research.

Conclusions:

• A comprehensive mechanistic taxonomy of PCD is needed to classify diverse cell death programs.
• Such a classification will provide deeper insights into cell death in various diseases.
• This approach holds potential for developing innovative therapeutic interventions for diseases involving aberrant cell death.